Equity
Total Equity
Boston Scientific Total Equity increased by 3.6% to $24.23B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 11.3%, from $21.77B to $24.23B. Over 5 years (FY 2020 to FY 2025), Total Equity shows an upward trend with a 9.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryMarket Position
SignalHigher is better
VolatilityStable
First reportedQ3 2013
Last reportedQ4 2025
How to read this metric
A growing equity base suggests increasing value for shareholders, though aggressive share buybacks can intentionally reduce this figure.
Detailed definition
The residual interest in the assets of the company after deducting all liabilities. It represents the net book value of...
Peer comparison
Used to calculate Return on Equity (ROE), a primary measure of how effectively management is using shareholder capital to generate profit.
Metric ID:
total_stockholders_equityHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $15.94B | $16.46B | $16.62B | $16.74B | $17.25B | $17.64B | $17.57B | $17.85B | $18.23B | $18.89B | $19.28B | $19.93B | $20.37B | $20.71B | $21.77B | $22.21B | $22.42B | $23.39B | $24.23B |
| QoQ Change | — | +3.3% | +1.0% | +0.7% | +3.1% | +2.3% | -0.4% | +1.6% | +2.1% | +3.6% | +2.1% | +3.3% | +2.2% | +1.7% | +5.1% | +2.0% | +0.9% | +4.4% | +3.6% |
| YoY Change | — | — | — | — | +8.2% | +7.2% | +5.7% | +6.7% | +5.7% | +7.1% | +9.7% | +11.6% | +11.8% | +9.6% | +12.9% | +11.5% | +10.0% | +13.0% | +11.3% |
Range$15.94B – $24.23B
CAGR+9.8%
Avg YoY Growth+9.5%
Median YoY Growth+9.7%
Current Streak12 quarters growth
Total Equity at Other Companies
Frequently Asked Questions
- What is Boston Scientific's total equity?
- Boston Scientific (BSX) reported total equity of $24.23B in Q4 2025.
- How has Boston Scientific's total equity changed year-over-year?
- Boston Scientific's total equity increased by 11.3% year-over-year, from $21.77B to $24.23B.
- What is the long-term trend for Boston Scientific's total equity?
- Over 5 years (2020 to 2025), Boston Scientific's total equity has grown at a 9.6% compound annual growth rate (CAGR), from $15.33B to $24.23B.
- What does total equity mean?
- The net worth of the company belonging to the owners, calculated as total assets minus total liabilities.